Alliance Pharma plc (APH.L)
GBp 46.4
(-2.62%)
GBp 46.4
(-2.62%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 180.68 Million | 167.41 Million | 163.2 Million | 129.8 Million | 135.63 Million | 118.2 Million |
| Cost of Revenue | 75.66 Million | 65.73 Million | 53.75 Million | 46.98 Million | 49.56 Million | 45.56 Million |
| Gross Profit | 105.01 Million | 101.68 Million | 109.45 Million | 82.81 Million | 86.07 Million | 72.64 Million |
| Operating Expenses | 60.03 Million | 72.88 Million | 81.72 Million | 54.44 Million | 48.63 Million | 43.72 Million |
| Selling, General and Administrative Expenses | 54.21 Million | 63.58 Million | 63.04 Million | 45.91 Million | 46.81 Million | 41.93 Million |
| Research and Development Expenses | - | - | - | - | 74 Thousand | 131 Thousand |
| Other Expenses | 89.24 Million | 9.29 Million | 18.68 Million | 8.52 Million | 1.81 Million | 1.79 Million |
| Cost and Expenses | 219.12 Million | 138.61 Million | 135.48 Million | 101.42 Million | 98.19 Million | 89.28 Million |
| Operating Income | -38.44 Million | 10.56 Million | 21.57 Million | 27.14 Million | 35.62 Million | 23.66 Million |
| Interest Expense | 9.99 Million | 4.78 Million | 3 Million | 2.07 Million | 3.28 Million | 3.03 Million |
| Income Tax Expense | -15.66 Million | 4.27 Million | 10.83 Million | 4.98 Million | 6.06 Million | 4.44 Million |
| Earnings before Tax | -48.8 Million | 5.2 Million | 18.15 Million | 13.01 Million | 31.07 Million | 22.8 Million |
| Net Income | -33.13 Million | 936 Thousand | 7.31 Million | 8.02 Million | 25.01 Million | 18.35 Million |
| Earnings Per Share Basic | -0.06 | 0.00 | 0.01 | 0.02 | 0.05 | 0.04 |
| Earnings Per Share Diluted | -0.06 | 0.00 | 0.01 | 0.01 | 0.05 | 0.04 |
| Weighted Average Shares Outstanding | 540.14 Million | 539.48 Million | 535.29 Million | 531.06 Million | 520.68 Million | 497.19 Million |
| Weighted Average Shares Outstanding (Diluted) | 540.14 Million | 545.28 Million | 542.33 Million | 537.31 Million | 530.15 Million | 510.42 Million |
| Gross Margin | 0.58 | 0.61 | 0.67 | 0.64 | 0.63 | 0.61 |
| EBIT Margin | -0.16 | 0.12 | 0.27 | 0.37 | 0.28 | 0.33 |
| Profit Margin | -0.18 | 0.01 | 0.04 | 0.06 | 0.18 | 0.16 |
| EBITDA | -28.94 Million | -6.85 Million | 31.9 Million | 24.58 Million | 36.52 Million | 27.75 Million |
| Earnings Before Tax Margin | -0.21 | 0.06 | 0.13 | 0.21 | 0.26 | 0.20 |
| Breakdown | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q2 | 2022 Q4 | 2022 FY |
|---|---|---|---|---|---|---|
| Revenue | 83.86 Million | 99.28 Million | 180.68 Million | 81.39 Million | 88.65 Million | 167.41 Million |
| Cost of Revenue | 38.04 Million | 46.68 Million | 85.98 Million | 39.29 Million | 43.03 Million | 65.73 Million |
| Gross Profit | 45.82 Million | 52.59 Million | 94.69 Million | 42.09 Million | 45.61 Million | 101.68 Million |
| Operating Expenses | 33.63 Million | 23.97 Million | 60.03 Million | 29.9 Million | 33.38 Million | 72.88 Million |
| Selling, General and Administrative Expenses | 33.63 Million | 23.97 Million | - | 29.9 Million | 33.38 Million | - |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | - | - | - | - | 9.29 Million |
| Cost and Expenses | 71.67 Million | 70.66 Million | 146.01 Million | 69.2 Million | 76.42 Million | 138.61 Million |
| Operating Income | 12.19 Million | 28.61 Million | 34.66 Million | 12.19 Million | 12.23 Million | 10.56 Million |
| Interest Expense | 4.93 Million | 5.87 Million | 9.53 Million | 4.6 Million | 3.41 Million | 4.78 Million |
| Income Tax Expense | 1.27 Million | -16.79 Million | -15.66 Million | 1.12 Million | 894 Thousand | 4.27 Million |
| Earnings before Tax | 5.94 Million | -55.03 Million | -48.8 Million | 6.23 Million | -11.27 Million | 5.2 Million |
| Net Income | 4.66 Million | -38.24 Million | -33.13 Million | 5.1 Million | -12.16 Million | 936 Thousand |
| Earnings Per Share Basic | 0.01 | -0.07 | - | 0.01 | -0.02 | - |
| Earnings Per Share Diluted | 0.01 | -0.07 | - | 0.01 | -0.02 | - |
| Weighted Average Shares Outstanding | 540.4 Million | 540.39 Million | 540.14 Million | 540.03 Million | 539.99 Million | 539.48 Million |
| Weighted Average Shares Outstanding (Diluted) | 544.19 Million | 540.39 Million | 540.14 Million | 541.57 Million | 539.99 Million | 545.28 Million |
| Gross Margin | 0.55 | 0.53 | 0.52 | 0.52 | 0.51 | 0.61 |
| EBIT Margin | 0.19 | 0.34 | - | 0.21 | 0.20 | - |
| Profit Margin | 0.06 | -0.39 | -0.18 | 0.06 | -0.14 | 0.01 |
| EBITDA | 15.71 Million | 34.17 Million | - | 16.95 Million | 17.65 Million | - |
| Earnings Before Tax Margin | 0.15 | 0.29 | 0.19 | 0.15 | 0.14 | 0.06 |
SZLMY
8137
FERRO
KCM
TRUE
688538